465 related articles for article (PubMed ID: 25933462)
1. Partial Oculocutaneous Albinism: Two Siblings with Features of both Hermansky Pudlak and Waardenburg's Syndrome.
Ishaq M; Niazi MK; Khan MS; Nadeem Y
J Coll Physicians Surg Pak; 2015 Apr; 25 Suppl 1():S43-4. PubMed ID: 25933462
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel mutation in HPS6 in a patient with hemophilia B and oculocutaneous albinism.
O'Brien KJ; Lozier J; Cullinane AR; Osorio B; Nghiem K; Speransky V; Zein WM; Mullikin JC; Neff AT; Simon KL; Malicdan MC; Gahl WA; Young LR; Gochuico BR
Mol Genet Metab; 2016 Nov; 119(3):284-287. PubMed ID: 27641950
[TBL] [Abstract][Full Text] [Related]
3. Hermansky-Pudlak syndrome and oculocutaneous albinism in Chinese children with pigmentation defects and easy bruising.
Power B; Ferreira CR; Chen D; Zein WM; O'Brien KJ; Introne WJ; Stephen J; Gahl WA; Huizing M; Malicdan MCV; Adams DR; Gochuico BR
Orphanet J Rare Dis; 2019 Feb; 14(1):52. PubMed ID: 30791930
[TBL] [Abstract][Full Text] [Related]
4. Syndromic albinism: a review of genetics and phenotypes.
Scheinfeld NS
Dermatol Online J; 2003 Dec; 9(5):5. PubMed ID: 14996378
[TBL] [Abstract][Full Text] [Related]
5. Posterior staphyloma in oculocutaneous albinism: another possible cause of reduced visual acuity.
Lee S; Schimmenti LA; King RA; Brilliant M; Anderson JL; Schoonveld C; Summers CG
J AAPOS; 2015 Dec; 19(6):562-4. PubMed ID: 26691042
[TBL] [Abstract][Full Text] [Related]
6. Molecular bases of congenital hypopigmentary disorders in humans and oculocutaneous albinism 1 in Japan.
Tomita Y; Miyamura Y; Kono M; Nakamura R; Matsunaga J
Pigment Cell Res; 2000; 13 Suppl 8():130-4. PubMed ID: 11041370
[TBL] [Abstract][Full Text] [Related]
7. P gene mutations in patients with oculocutaneous albinism and findings suggestive of Hermansky-Pudlak syndrome.
Garrison NA; Yi Z; Cohen-Barak O; Huizing M; Hartnell LM; Gahl WA; Brilliant MH
J Med Genet; 2004 Jun; 41(6):e86. PubMed ID: 15173252
[No Abstract] [Full Text] [Related]
8. [Hypomelanoses transmitted from generation to generation].
Otręba M; Buszman E; Miliński M; Wrześniok D
Postepy Hig Med Dosw (Online); 2014 Sep; 68():1081-90. PubMed ID: 25228517
[TBL] [Abstract][Full Text] [Related]
9. Severe bleeding with subclinical oculocutaneous albinism in a patient with a novel HPS6 missense variant.
Han CG; O'Brien KJ; Coon LM; Majerus JA; Huryn LA; Haroutunian SG; Moka N; Introne WJ; Macnamara E; Gahl WA; Malicdan MCV; Chen D; Krishnan K; Gochuico BR
Am J Med Genet A; 2018 Dec; 176(12):2819-2823. PubMed ID: 30369044
[TBL] [Abstract][Full Text] [Related]
10. Biallelic mutations in AP3D1 cause Hermansky-Pudlak syndrome type 10 associated with immunodeficiency and seizure disorder.
Mohammed M; Al-Hashmi N; Al-Rashdi S; Al-Sukaiti N; Al-Adawi K; Al-Riyami M; Al-Maawali A
Eur J Med Genet; 2019 Nov; 62(11):103583. PubMed ID: 30472485
[TBL] [Abstract][Full Text] [Related]
11. Exome sequencing identifies SLC24A5 as a candidate gene for nonsyndromic oculocutaneous albinism.
Wei AH; Zang DJ; Zhang Z; Liu XZ; He X; Yang L; Wang Y; Zhou ZY; Zhang MR; Dai LL; Yang XM; Li W
J Invest Dermatol; 2013 Jul; 133(7):1834-40. PubMed ID: 23364476
[TBL] [Abstract][Full Text] [Related]
12. [Oculocutaneous albinism].
Lacour JP; Ortonne JP
Ann Pediatr (Paris); 1992 Sep; 39(7):409-18. PubMed ID: 1416662
[TBL] [Abstract][Full Text] [Related]
13. Ocular findings and a comparative study of hair, skin and iris color in Chinese patients with albinism.
Arcot Sadagopan K; Teng CH; Hui G; Lin DL
Ophthalmic Genet; 2023 Feb; 44(1):54-69. PubMed ID: 36316991
[TBL] [Abstract][Full Text] [Related]
14. Clinical phenocopies of albinism.
Dumitrescu AV; Pfeifer WL; Drack AV
J AAPOS; 2021 Aug; 25(4):220.e1-220.e8. PubMed ID: 34280564
[TBL] [Abstract][Full Text] [Related]
15. Genetics of non-syndromic and syndromic oculocutaneous albinism in human and mouse.
Fernández A; Hayashi M; Garrido G; Montero A; Guardia A; Suzuki T; Montoliu L
Pigment Cell Melanoma Res; 2021 Jul; 34(4):786-799. PubMed ID: 33960688
[TBL] [Abstract][Full Text] [Related]
16. Color vision in patients with the Hermansky-Pudlak syndrome.
Rodríguez JA; Blasini M; Blasini M; Townsend W; Izquierdo NJ
Bol Asoc Med P R; 2004; 96(2):84-90. PubMed ID: 15580910
[TBL] [Abstract][Full Text] [Related]
17. Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky-Pudlak syndrome type 1 and 3 mutations in Puerto Rico.
Santiago Borrero PJ; Rodríguez-Pérez Y; Renta JY; Izquierdo NJ; Del Fierro L; Muñoz D; Molina NL; Ramírez S; Pagán-Mercado G; Ortíz I; Rivera-Caragol E; Spritz RA; Cadilla CL
J Invest Dermatol; 2006 Jan; 126(1):85-90. PubMed ID: 16417222
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Mutation Spectrum of Autosomal Recessive Non-Syndromic Oculocutaneous Albinism (nsOCA) in Pakistan: A Review.
Ullah MI
Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741834
[TBL] [Abstract][Full Text] [Related]
19. Clinico-molecular analysis of eleven patients with Hermansky-Pudlak type 5 syndrome, a mild form of HPS.
Michaud V; Lasseaux E; Plaisant C; Verloes A; Perdomo-Trujillo Y; Hamel C; Elcioglu NH; Leroy B; Kaplan J; Jouk PS; Lacombe D; Fergelot P; Morice-Picard F; Arveiler B
Pigment Cell Melanoma Res; 2017 Jan; 30(6):563-570. PubMed ID: 28640947
[TBL] [Abstract][Full Text] [Related]
20. The hermansky-pudlak syndrome: clinical features and imperatives from an ophthalmic perspective.
Schneier AJ; Fulton AB
Semin Ophthalmol; 2013; 28(5-6):387-91. PubMed ID: 24138047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]